Skip to Main Content

Paper Details

Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma.
Cancer Res
29
2020
Medulloblastoma, PDX, PDXs, actinomycin D, children, malignant brain tumors, medulloblastoma, medulloblastomas, orthotopic patient-derived xenografts, patient, patients, sarcoma, tumor, tumor cells, tumors
Author NameAffiliation
Jessica M RusertNCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Sebastian BrabetzHopp Children's Cancer Center (KiTZ)
Sebastian BrabetzGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Sebastian BrabetzHopp Children's Cancer Center (KiTZ)
Sebastian BrabetzGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
James JensenUniversity of California San Diego
James JensenMoores Cancer Center, University of California San Diego
Alexandra GarancherNCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Huriye Seker-CinHopp Children's Cancer Center (KiTZ)
Huriye Seker-CinGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Susanne Gr??bnerHopp Children's Cancer Center (KiTZ)
Susanne Gr??bnerGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Susanne Gr??bnerHopp Children's Cancer Center (KiTZ)
Susanne Gr??bnerGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Lin QiTexas Children's Cancer Center, Baylor College of Medicine
Patricia BaxterTexas Children's Cancer Center, Baylor College of Medicine
Patricia BaxterAnn & Robert H. Lurie Children's Hospital of Chicago, Northwestern University
Michael E BerensThe Translational Genomics Research Institute
Till MildeHopp Children's Cancer Center (KiTZ)
Till MildeGerman Cancer Research Center (DKFZ)
Till MildeUniversity Hospital Heidelberg
Xiao-Nan LiTexas Children's Cancer Center, Baylor College of Medicine
Xiao-Nan LiAnn & Robert H. Lurie Children's Hospital of Chicago, Northwestern University
James M OlsonFred Hutchinson Cancer Research Center and Seattle Children's Hospital
David DimmockRady Children's Institute for Genomic Medicine
John R CrawfordRady Children's Hospital
John R CrawfordUniversity of California San Diego
John R CrawfordUniversity of California San Diego
John R CrawfordRady Children's Hospital
John R CrawfordUniversity of California San Diego
John R CrawfordUniversity of California San Diego
Eliezer M Van AllenDana-Farber Cancer Institute, Harvard Medical School
Eliezer M Van AllenBroad Institute of Massachusetts Institute of Technology and Harvard
Eliezer M Van AllenDana-Farber Cancer Institute, Harvard Medical School
Eliezer M Van AllenBroad Institute of Massachusetts Institute of Technology and Harvard
Stefan M PfisterHopp Children's Cancer Center (KiTZ)
Stefan M PfisterUniversity Hospital Heidelberg
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan M PfisterHopp Children's Cancer Center (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan M PfisterUniversity Hospital Heidelberg
Pablo TamayoUniversity of California San Diego
Pablo TamayoMoores Cancer Center, University of California San Diego
Pablo TamayoUniversity of California San Diego
Pablo TamayoMoores Cancer Center, University of California San Diego
Marcel KoolHopp Children's Cancer Center (KiTZ)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Marcel KoolHopp Children's Cancer Center (KiTZ)
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
  • 1 - 50

Datasets